Pages

▼
Friday, September 30, 2022

Building New Data Connections Helps Brands Lower Adherence Barriers

›
Today’s guest post comes from Kylie Hall, Director of Product Management at ConnectiveRx. Kylie explains how new ways of harnessing patien...
Tuesday, September 27, 2022

Drug Channels News Roundup, September 2022: Patients vs. SaveonSP, PBMs’ Oncology Exclusions, Medicare Advantage Winners, HRSA’s 340B Reveal, and New DCI Offerings

›
Autumn is here! Please savor these Drug Channels acorns that we’ve squirrelled away for you: One patient’s troubling experience with Saveo...
Friday, September 23, 2022

Managing 340B, Medicaid Drug Discounts: Technology for Collaboration – Anywhere, Anytime

›
Today’s guest post comes from Lindsey Alves, Vice President of Customer Success at Kalderos. Lindsey describes the challenges facing remot...
Wednesday, September 21, 2022

White Bagging Update 2022: Hospitals Battle to Boost Buy-and-Bill

›
The battle for control of the specialty patient continues. In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitut...
Tuesday, September 20, 2022

Available for Preorder: The 2022-23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

›
On October 11, 2022, Drug Channels Institute will release The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributo...
Friday, September 16, 2022

The Pulse of Electronic Benefit Verification Solutions: Know the Facts

›
Today’s guest post comes from Edward Hensley, Chief Commercial Officer at AssistRx. Edward compares the pros and cons of electronic benefi...
Wednesday, September 14, 2022

NEW: The Drug Channels 2023 Video Webinar Series

›
I invite you to join me for three new video webinars during 2023. These live, interactive events will be broadcast via Zoom from the Drug Ch...
Tuesday, September 13, 2022

The Inflation Reduction Act: Three Unintended Consequences for Biosimilars, Health Plans, Providers, and Pharmacies

›
By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. 117-169). Today...
Friday, September 09, 2022

Patients At Risk As Healthcare Navigates Affordability

›
Today’s guest post comes from Kristina Crockett, Vice President of Product Management at CoverMyMeds. Kristina discusses the affordability ...
Wednesday, September 07, 2022

The Biosimilar Boom and the Coming Humira Price War (Video)

›
As regular readers know, the biosimilar boom for provider-administered drugs has been accelerating. Prices are dropping while adoption accel...
Friday, August 26, 2022

Your Brand Just Got Added to a Must-Have Formulary: Now What?

›
Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. Chris discusses the benefits of usi...
Tuesday, August 23, 2022

Drug Channels News Roundup, August 2022: Gov. Dean vs. Maximizers, Cancer vs. Copays, Specialty Drug Trends, Biosimilar Transitivity, and Dr. G. vs. PBMs

›
Our news-laden summer is coming to an end. Time to pack away your bathing suit, send the kids back to school, and cherish these curated curi...